Moneyfarm, the Italian fintech scaleup dedicated to the management of savings with a digital approach, has launched Moneyfarm Score, a predictive model of players’ value.
To date, the global benchmark for players’ prices is the real time price calculated by the Transfermarkt platform, which since 2008 has been owned by German publisher Axel Springer. However, the idea of Moneyfarm seems to go further because the goal would be to predict the future value of players.
Find out more about the newly launched Moneyfarm Score and read the most important finance news with the Born2Invest mobile app.
How was the algorithm created and how it works
The algorithm was developed by examining about 100 player purchases (market hits) of the Serie A teams in summer 2019 and applying some methodologies and techniques usually used by Moneyfarm for the management of financial assets. In detail, Moneyfarm builds the score through the evaluation of some statistical data of players and regression models (developed by regressing statistics such as, for example, goals, age, team of origin, trophies won, Champions League appearances, media prominence of the player), thus estimating the fair value of the player. This value is then parameterized to the cost of salary and the cost of the card, so as to obtain the final score.
Vincenzo Cuscito, Senior Investment Consultant of Moneyfarm, explained: “In soccer, as in finance, numbers are not everything and there are nuances and intrinsic aspects that the algorithms fail to grasp, so all our investment choices are validated by a team of experts. In both cases it is an activity that requires an estimate of the opportunity cost of each asset and to predict their return over time. To do this it is necessary to analyze reality through data, observe the numbers and transform them into trends using statistics and algorithms. The score is an experiment that aims to give fans an extra cue to evaluate the market hits. We can’t wait to put our algorithm to the test so that we can collect the necessary data to further refine it in view of the next market sessions.”
Founded by Paolo Galvani and Giovanni Daprà in 2011 and specializing in online financial consulting and above all in asset management in Etf portfolios, Moneyfarm to date has obtained over $130 million (€110 million) loans, the last of which, from $47.4 million (€40 million), in September 2019, led by Poste Italiane and in which Allianz Asset Management, a former shareholder of the company, participated. The previous round, for $54.5 million (€46 million), was closed in May 2018.
Moneyfarm is the only digital wealth manager in Europe to pursue continental expansion with a presence in three markets (Italy, UK, and Germany). In October 2017 the fintech company acquired Ernest, a London startup founded in 2016 by three Italian developers (Cristoforo Mione, Lorenzo Sicilia, and Niall Bellabarba), a personal banker powered by artificial intelligence.
Moneyfarm, regulated by the Financial Conduct Authority (FCA) and supervised in Italy by Consob, thus becomes the first digital manager to explore the use of chatbots for savings and investment management.
In November 2018 Moneyfarm acquired Vaamo, the first independent digital asset manager in Germany. Last June, Moneyfarm launched its first supplementary pension solution: an Individual Pension Plan (PIP), called the Moneyfarm Pension Plan.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Be Beez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Rovi will also produce Moderna’s COVID-19 vaccine in Andalusia
Rovi will start producing Moderna's COVID-19 vaccine in Andalusia. This investment consists of the installation of a new line to...
Moroccan-Spanish borders: towards a return to normal?
Preparations are underway to mark the next edition of the Marhaba operation, to facilitate the transit of Moroccans from around...
NBA players will be able to choose whether to be paid in cryptocurrencies
NBA players will now have the possibility to take their salaries in cryptocurrencies. After the ok for the purchase of...
How the USDA WASDE report influenced futures markets
Soybeans and Soybean Meal were lower with a lot of the selling developing on Friday in response to the USDA...
Digitization of financial services gives wings to fintech companies to reinvent the industry
Creators of increasingly popular solutions such as mobile applications and digital payments, the leaders of the fintech ecosystem will play...
Crypto7 days ago
Algorand and Siae launch copyright tokenization
Featured7 days ago
CAC 40 ESG: Should you invest in the new index?
Biotech7 days ago
GSK, Lilly and Vir Biotechnology achieve positive results in Phase II COVID-19 study
Africa7 days ago
National tourism management in Morocco: why a framework law is needed